tiprankstipranks
Trending News
More News >
MiMedx Group Inc. (MDXG)
:MDXG
US Market

MiMedx Group (MDXG) Stock Statistics & Valuation Metrics

Compare
491 Followers

Total Valuation

MiMedx Group has a market cap or net worth of $1.03B. The enterprise value is $921.13M.
Market Cap$1.03B
Enterprise Value$921.13M

Share Statistics

MiMedx Group has 148,102,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding148,102,160
Owned by Insiders2.13%
Owned by Institutions37.57%

Financial Efficiency

MiMedx Group’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.56%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)19.56%
Return on Capital Employed (ROCE)0.27
Revenue Per Employee416.82K
Profits Per Employee50.18K
Employee Count837
Asset Turnover1.32
Inventory Turnover2.52

Valuation Ratios

The current PE Ratio of MiMedx Group is 25.4. MiMedx Group’s PEG ratio is -0.84.
PE Ratio25.4
PS Ratio4.05
PB Ratio7.32
Price to Fair Value7.32
Price to FCF21.92
Price to Operating Cash Flow14.58
PEG Ratio-0.84

Income Statement

In the last 12 months, MiMedx Group had revenue of 348.88M and earned 42.42M in profits. Earnings per share was 0.29.
Revenue348.88M
Gross Profit288.81M
Operating Income58.87M
Pretax Income57.29M
Net Income42.42M
EBITDA65.35M
Earnings Per Share (EPS)0.29

Cash Flow

In the last 12 months, operating cash flow was 194.32M and capital expenditures -16.43M, giving a free cash flow of 177.89M billion.
Operating Cash Flow194.32M
Free Cash Flow177.89M
Free Cash Flow per Share1.20

Dividends & Yields

MiMedx Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.74
52-Week Price Change-26.22%
50-Day Moving Average7.00
200-Day Moving Average7.00
Relative Strength Index (RSI)50.62
Average Volume (3m)1.03M

Important Dates

MiMedx Group upcoming earnings date is Mar 4, 2026, Before Open (Not Confirmed).
Last Earnings DateOct 29, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date

Financial Position

MiMedx Group as a current ratio of 4.21, with Debt / Equity ratio of 0.58%
Current Ratio4.21
Quick Ratio3.69
Debt to Market Cap0.01
Net Debt to EBITDA-1.22
Interest Coverage Ratio58.51

Taxes

In the past 12 months, MiMedx Group has paid 15.30M in taxes.
Income Tax15.30M
Effective Tax Rate0.27

Enterprise Valuation

MiMedx Group EV to EBITDA ratio is 20.42, with an EV/FCF ratio of 20.68.
EV to Sales3.82
EV to EBITDA20.42
EV to Free Cash Flow20.68
EV to Operating Cash Flow20.16

Balance Sheet

MiMedx Group has $142.08M in cash and marketable securities with $18.21M in debt, giving a net cash position of $123.87M billion.
Cash & Marketable Securities$142.08M
Total Debt$18.21M
Net Cash$123.87M
Net Cash Per Share$0.84
Tangible Book Value Per Share$1.10

Margins

Gross margin is 81.99%, with operating margin of 16.87%, and net profit margin of 12.16%.
Gross Margin81.99%
Operating Margin16.87%
Pretax Margin16.42%
Net Profit Margin12.16%
EBITDA Margin18.73%
EBIT Margin17.00%

Analyst Forecast

The average price target for MiMedx Group is $12.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.00
Price Target Upside77.78% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast14.77%
EPS Growth Forecast-58.90%

Scores

Smart Score7
AI Score